Evidence map›Paper›PMID 25271406›Full record

ArticleEmerging infectious diseases2014

Clinical isolates of Shiga toxin 1a-producing Shigella flexneri with an epidemiological link to recent travel to Hispañiola.

Miranda D Gray, Keith A Lampel, Nancy A Strockbine, Reinaldo E Fernandez, Angela R Melton-Celsa, Anthony T Maurelli

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. International journal of molecular sciences · 2024
    Review
  6. Review
  7. GeneratingFrontiers in oncology · 2023
    Article
  8. ABToxins · 2022
    Review
  9. Article
  10. Article
  11. FightingJournal of medicinal chemistry · 2021
    Article
  12. Improved Genomic Identification, Clustering, and Serotyping of Shiga Toxin-ProducingFrontiers in cellular and infection microbiology · 2021
    Article
  13. Ecology, Structure, and Evolution ofAnnual review of virology · 2020
    Review
  14. Review
  15. Genome Analysis of a HistoricalFrontiers in microbiology · 2020
    Article
  16. Access microbiology · 2020
    Article
  17. Review
  18. Applied and environmental microbiology · 2019
    Article
  19. Genomic and Proteomic Characterizations ofFrontiers in microbiology · 2019
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Miranda D Gray
Keith A Lampel
Nancy A Strockbine
Reinaldo E Fernandez
Angela R Melton-Celsa
Anthony T Maurelli
Uniformed Services University of the Health Sciences · USUnited States Food and Drug Administration · US

Funding

TEMPERATURE REGULATION OF SHIGELLA VIRULENCE GENESR01AI024656 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI MAURELLI, ANTHONY T · 1989 to 2013
$3.8M
Pathogenicity of Shiga Toxin Producing E.coliR37AI020148 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI O'BRIEN, ALISON DAVIS · 2008 to 2016
$3.8M
SHIGA-LIKE TOXIN OF ESCHERICHIA COLIR01AI020148 · NIAID · U.S. UNIFORMED SERVICES UNIV OF HLTH SCI · PI MELTON-CELSA, ANGELA · 1987 to 2017
$3.3M
SHIGA-LIKE TOXIN OF ESCHERICHIA COLIR22AI020148 · NIAID · U.S. UNIFORMED SERVICES UNIV OF HLTH SCI · PI O'BRIEN, ALISON DAVIS · 1985 to 1991
–
NIAID NIH HHS AI020148NIAID NIH HHS R01 AI020148NIAID NIH HHS R01 AI024656NIAID NIH HHS R01AI24656NIAID NIH HHS R37 AI020148
6 · The paper itself

Abstract

Shiga toxins (Stx) are cytotoxins involved in severe human intestinal disease. These toxins are commonly found in Shigella dysenteriae serotype 1 and Shiga-toxin-producing Escherichia coli; however, the toxin genes have been found in other Shigella species. We identified 26 Shigella flexneri serotype 2 strains isolated by public health laboratories in the United States during 2001-2013, which encode the Shiga toxin 1a gene (stx1a). These strains produced and released Stx1a as measured by cytotoxicity and neutralization assays using anti-Stx/Stx1a antiserum. The release of Stx1a into culture supernatants increased ≈100-fold after treatment with mitomycin C, suggesting that stx1a is carried by a bacteriophage. Infectious phage were found in culture supernatants and increased ≈1,000-fold with mitomycin C. Whole-genome sequencing of several isolates and PCR analyses of all strains confirmed that stx1a was carried by a lambdoid bacteriophage. Furthermore, all patients who reported foreign travel had recently been to Hispañiola, suggesting that emergence of these novel strains is associated with that region.

Indexed as

AnimalsChlorocebus aethiopsDominican RepublicDysentery, BacillaryGene Expression Regulation, BacterialHaitiHumansLysogenyMitomycinMutationProphagesSerogroupShiga Toxin 1Shigella flexneriSiphoviridaeVero CellsMitomycinShiga Toxin 1

Identifiers

PMID25271406
PMCPMC4193171
OpenAlexW2119912115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.